PubRank

A Murgo

Author PubWeight™ 13.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms. J Clin Oncol 2001 1.41
2 Homoharringtonine: history, current research, and future direction. Cancer 2001 1.25
3 Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Clin Cancer Res 2000 0.98
4 Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature. Arch Intern Med 1997 0.95
5 Clinical trials referral resource. Clinical trials of MGI-114. Oncology (Williston Park) 1999 0.93
6 Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia. J Clin Oncol 2000 0.87
7 Lymphadenopathy in celiac disease: not always a sign of lymphoma. Am J Gastroenterol 1988 0.86
8 A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome. Hum Gene Ther 2009 0.82
9 Phase II study of bryostatin 1 in patients with relapsed multiple myeloma. Invest New Drugs 2001 0.82
10 Levels of chemerin and interleukin 8 in the synovial fluid of patients with inflammatory arthritides and osteoarthritis. Clin Exp Rheumatol 2014 0.81
11 Novel therapeutic agents for the treatment of myelodysplastic syndromes. Semin Oncol 2000 0.81
12 [Simultaneous ultrasonography and arthroscopy for the study of the joint environment: indications and limits]. Reumatismo 2007 0.80
13 Human responses against HER-2-positive cancer cells in human immune system-engrafted mice. Br J Cancer 2012 0.78
14 [Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial]. G Ital Nefrol 2013 0.77
15 Effectiveness and safety of leflunomide in the clinical practice. A different experience. Clin Exp Rheumatol 2007 0.75
16 Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract. J Clin Oncol 1999 0.75
17 Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia. Invest New Drugs 2001 0.75
18 Over-the-counter ibuprofen and acute renal failure. Ann Intern Med 1986 0.75